ImmuneWalk Therapeutics

ImmuneWalk TherapeuticsImmuneWalk TherapeuticsImmuneWalk Therapeutics
  • Home
  • New Biology
  • Our Technology
  • Clinical Program
  • Market Potential
  • News & Events
  • More
    • Home
    • New Biology
    • Our Technology
    • Clinical Program
    • Market Potential
    • News & Events
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

ImmuneWalk Therapeutics

ImmuneWalk TherapeuticsImmuneWalk TherapeuticsImmuneWalk Therapeutics

Signed in as:

filler@godaddy.com

  • Home
  • New Biology
  • Our Technology
  • Clinical Program
  • Market Potential
  • News & Events

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

TAMI RACHMILEWITZ, M.D.

Chief medical officer

Dr. Tami Rachmilewitz is a clinical research physician executive with over 20 years of experience in the Pharmaceutical Industry. Prior to joining ImmuneWalk she served as the Senior Vice President of Clinical Development at VBL Therapeutics responsible for all clinical aspects of the company’s development programs. 


Prior to VBL, Dr. Rachmilewitz held medical positions at Teva, Novartis & Neuroderm, working on early and late stage programs, mainly in the therapeutic areas of Neurology and Immunology. She holds an MD from the Medical School at the Hebrew University in Jerusalem, and trained in Psychiatry at the Hadassah Medical Center in Jerusalem.

Tami Rachmilewitz, M.D. - Chief Medical Officer

Copyright © 2025 ImmuneWalk Therapeutics - All Rights Reserved.

Powered by

  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept